Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 30, 2017 11:00 ET | Source: ContraFect Corporation

ContraFect Awarded Funding from CARB-X to Support Gram-Negative Lysin Program

YONKERS, NY--(Marketwired - March 30, 2017) - ContraFect Corporation (NASDAQ: CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for...